Study to Evaluate the Diagnostic Performance of of MAGENTIQ-COLO During Colonoscopy.
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-80
SponsorMagentiq Eye LTD
About this trial
This is an international, multicenter, study to evaluate the diagnostic performance of the CADx polyp sizing modality of the MAGENTIQ-COLO.
Eligibility criteria
Qualifiers
Individuals aged ≥45 - ≤80 years old, who are scheduled for non-iFOBT screening or surveillance colonoscopy.
Disqualifiers
In situ polyps with known histology detected in a previous colonoscopy.
No colorectal polyps detected during colonoscopy.
Known or suspected inflammatory bowel disease.
Polyposis syndrome (e.g., familial adenomatous polyposis, serrated polyposis).
Trial design
Treatments tested in this trial
- MAGENTIQ-COLO.
Treatment groups
330 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov